Peptide Linkers_Val-Cit
Peptide Linkers are developed as the critical component of ADC linkers which play vital roles in the overall success of the ADC. By introducing a PEG into the linker, it increases the water-solubility and helping finetune the drug DMPK. A well-designed linker helps the antibody to selectively deliver a cytotoxic drug to tumor cells and accurately releases the drug at tumor site. Two kinds of ADC linkers are used in current ADC drugs: cleavable linkers and non-cleavable linkers.
Catalog No.
|
Product Name
|
M.W
|
Purity
|
Size
|
Structure
|
BP-24335
|
Val-Cit
|
274.3
|
98%
|
250, 500 mg & 1 g
|
|
BP-23218
|
Val-Cit-PAB-OH
|
379.5
|
95%
|
500 mg, 1 & 5 g
|
|
BP-23219
|
Fmoc-Val-Cit-PAB-OH
|
601/7
|
95%
|
250, 500 mg & 1 g
|
|
BP-22309
|
Fmoc-Val-Cit-PAB-PNP
|
766.8
|
95%
|
100, 500 mg & 1 g
|
|
BP-24173
|
Boc-Val-Cit
|
374.4
|
95%
|
250, 500 mg & 1 g
|
|
BP-24174
|
Boc-Val-Cit-PAB
|
479.6
|
95%
|
250, 500 mg & 1 g
|
|
BP-24175
|
Boc-Val-Cit-PAB-PNB
|
644.7
|
95%
|
250, 500 mg & 1 g
|
|
BP-24363
|
MC (C5)-Val-Cit
|
452.5
|
98%
|
100, 250 & 500 mg
|
|
BP-23201
|
MC-Val-Cit-PAB-OH
|
572.7
|
96%
|
500 mg, 1 & 2 g
|
|
BP-23292
|
MC-Val-Cit-PAB-PNP
|
737.8
|
95%
|
100, 500 mg & 1 g
|
|
BP-24350
|
SPDP-Val-Cit-PAB-OH
|
576.7
|
98%
|
5, 10 & 25 mg
|
|
BP-24353
|
SPDP-Val-Cit-PAB-PNP
|
741.8
|
98%
|
5, 10 & 25 mg
|
|
BP-23203
|
Mal-PEG2-Val-Cit-PAB-OH
|
618.7
|
95%
|
10, 25 & 50 mg
|
|
BP-23204
|
Mal-PEG4-Val-Cit-PAB-OH
|
706.8
|
96%
|
50, 100 & 250 mg
|
|
BP-24314
|
Mal-PEG1-Val-Cit-PAB-PNP
|
739.7
|
96%
|
50, 100 & 250 mg
|
|
BP-23668
|
Mal-PEG4-Val-Cit-PAB-PNP
|
871.9
|
97%
|
50, 100 & 250 mg
|
|
BP-24348
|
Mal-amido-PEG2-Val-Cit-PAB-OH
|
689.8
|
98%
|
50, 100 & 250 mg
|
|
BP-23675
|
Mal-amido-PEG2-Val-Cit-PAB-PNP
|
854.9
|
98%
|
50, 100 & 250 mg
|
|
BP-23205
|
Azido-PEG1-Val-Cit-PAB-OH
|
520.6
|
96%
|
100, 250 & 500 mg
|
|
BP-23206
|
Azido-PEG3-Val-Cit-PAB-OH
|
608.7
|
96%
|
100, 250, 500 mg & 1g
|
|
BP-23207
|
Azido-PEG4-Val-Cit-PAB-OH
|
652.8
|
96%
|
100, 250, 500 mg & 1g
|
|
BP-23368
|
Azido-PEG3-Val-Cit-PAB-PNP
|
773.8
|
95%
|
50, 100 & 250 mg
|
|
BP-24340
|
BCN-PEG3-Val-Cit
|
653.8
|
98%
|
50, 100 & 250 mg
|
|
BP-24334
|
BCN-PEG3-VC-PFP Ester
|
819.8
|
96%
|
50, 100, 250 & 500 mg
|
|
BP-24520
|
DBCO-PEG4-Val-Cit-PAB-PNP
|
1079.2
|
98%
|
50, 100 & 250 mg
|
|
BP-24514
|
TCO-PEG4-Val-Cit-PAB-PNP
|
944.1
|
98%
|
25 mg
|
|
|